Case Report: Electroencephalography-informed low-frequency repetitive transcranial magnetic stimulation targeting the supplementary motor area in severe functional movement disorder

Psychology ~4 min read ▶ 6 min listen
Jordan Jordan Dr. Liang Dr. Liang

In short

A case report details using brain stimulation guided by EEG to treat tremors caused by a workplace accident. The hosts discuss the potential for this precision approach, noting that insurance coverage hinges on proving reliability across many patients, creating a financial gap for those needing treatment. They highlight the importance of focusing on the patient's immediate need for relief.

One idea raised: Considering the immediate financial burden on patients awaiting treatment can be more important than anticipating long-term economic shifts.

0:0006:15

You are not invisible. Most people are just busy looking at their own reflection.

JordanThis one's been sitting with me all day: Case Report: Electroencephalography-informed low-frequency repetitive transcranial magnetic stimulation targeting the supplementary motor area in severe functional movement disorder. Curious if it hits you the same way.

Dr. LiangThe real question isn't whether the machine works, but why we waited this long to map the brain activity behind a tremor caused by a workplace accident. For the person stuck in pain, knowing that their nervous system can be nudged back into rhythm changes everything about how they see their own body. That distinction between a broken part and a misfiring circuit is the entire game here.

JordanA single patient in a case report doesn't tell you who's paying for this kind of specialized setup yet. Until you scale it beyond one office, you're looking at a niche service where the insurance companies are definitely going to push back hard on coverage.

Dr. LiangYou’re fixated on the billing code when the breakthrough is that the EEG guided the stimulator to the supplementary motor area specifically. Without that mapping, you’d just be zapping random spots, and nobody’s insurer covers guesswork. The data says precision is what makes this viable, not the size of the clinic.

JordanPicture a factory worker with a shaking hand trying to hold a coffee cup without spilling it everywhere. Insurance won't cover a fancy EEG-guided zap just because it worked once in a journal; they'll deny it until someone proves it fixes the daily mess reliably across hundreds of people, not just one lucky case.

Dr. LiangPicture a nurse whose hands shake badly enough that she can’t fill prescriptions safely anymore—insurance denies her standard therapy as “experimental,” then quietly approves the same rTMS protocol three months later once a regional network publishes consistent results. The denial isn’t permanent; it’s the gap while data catches up to the first successful case, and that lag shrinks every time another site replicates the EEG-targeted approach.

JordanSo the "gap" is actually a funding hole that leaves the nurse out of work while the data matures. Who covers those lost wages during the wait?

Dr. LiangYou hit on a real problem there—the wage loss during that replication window is genuine economic damage no clinical trial accounts for. But that gap is shrinking precisely because each new site publishing consistent EEG-targeted results compresses the time between the first success and the next approval cycle. The underlying trend is that the evidence base grows faster than the bureaucracy can move to block it, even if the individual still pays the price in the meantime.

JordanYou nailed the point that the evidence compounds faster than the red tape can catch up, which is exactly the signal I look for before betting on a sector. The missing piece is the hardware cost itself; high-end EEG arrays plus calibrated TMS coils run tens of thousands per unit, meaning the initial capital outlay forces providers to charge premium rates that most injured workers simply cannot afford upfront regardless of eventual reimbursement.

Dr. LiangTreating the startup cost like a permanent wall is a bit like judging a library by its building permit rather than how many books get read inside. The capital expenditure is front-loaded, but the marginal cost of running the stimulation drops sharply after the equipment is paid off. What matters for affordability is the recurring treatment fee over time, not the invoice for the machine sitting in the corner.

JordanI think you're answering a different question than the one I asked.

Dr. LiangThen let's agree on the actual barrier: the patient faces a bill today, not a capital budget tomorrow. That immediate cash flow is the real friction point.

JordanAnd that’s where the insurer wins big—they pay zero upfront while the provider eats the debt service. The worker gets stuck holding the bag either way, whether it’s a lump sum or monthly installments.

Dr. LiangCalling the insurer’s delayed payment a win ignores that they are merely shifting the risk onto a provider balance sheet, not creating value. The real signal here is that the total cost of care remains static while the administrative burden absorbs a growing share of every dollar spent. Focus on where the money actually goes, not who writes the check last.

JordanYou’re chasing the ledger when the trade is happening at the counter. Injured workers lose their income stream immediately, while insurers bank the delay premium without lifting a finger. That’s the only margin worth watching in this whole setup.

Dr. LiangYou are measuring the transaction fee, not the asset’s value, and calling that fee the entire market. The delay premium evaporates once the insurance payout clears, leaving behind the durable shift in long-term disability costs and employer productivity retention. That structural change, not the weekly cash flow hiccup, is what determines the ultimate bottom line for everyone involved.

JordanYou keep waiting for the macro trend to confirm what the daily P&L has already shown. Until we know if the post-stimulation tremor reduction holds long enough to offset the initial therapy fees, your "structural shift" is just speculation. The worker needs relief now, not a future productivity chart.

Read next

Dialogues on the same topic

Other dialogues in Psychology

See all in this world →